Login / Signup

Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort.

Mathieu UzzanClément BresteauDavid LaharieCarmen StefanescuChristophe BellangerFranck CarbonnelMélanie SerreroStéphanie ViennotMaria NachuryAurélien AmiotRomain AltweggLaurence PiconStéphane NahonLucine VuittonPhilippe Ah SouneJulien KirchgesnerLaurent Peyrin BirouletYoram Bouhniknull null
Published in: Alimentary pharmacology & therapeutics (2021)
Tofacitinib appears as a promising option in patients hospitalised with a UC flare but needs further validation in controlled trials.
Keyphrases
  • end stage renal disease
  • ulcerative colitis
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • rheumatoid arthritis
  • peritoneal dialysis
  • patient reported outcomes
  • early onset
  • patient reported